Enhancing Neurovascular Care through Innovation
Acute stroke and traumatic brain injury start the same way: a non-contrast CT to rule out hemorrhage. For trauma, that’s often the whole picture. For stroke, once hemorrhage is ruled out, CT angiography locates the occlusion, and that same non-contrast scan is scored for ASPECTS to determine treatment eligibility. Each read is different, and at some centers, so is the specialist. Avicenna.AI’s tools cover both pathways, running automatically on the same infrastructure.
One patient. Three decisions
Step 1 — Intracranial Hemorrhage
The first scan is always a non-contrast CT. Before anything else is decided, hemorrhage has to be ruled out, CINA-ICH flags it before the radiologist opens the case.
Step 2 — Large Vessel Occlusion
Once hemorrhage is excluded, the CTA looks for the occlusion. CINA-LVO flags it immediately, so the interventional team doesn't wait on the full report.
Step 3 — ASPECT Scoring
If CINA-LVO confirms an occlusion, that same NCCT gets scored for ASPECTS, the number that determines treatment eligibility. CINA-ASPECTS returns it automatically.
FREQUENTLY ASKED QUESTIONS
Avicenna.AI offers three CE-marked and FDA-cleared AI tools for neurovascular CT imaging: CINA-ICH for automatic detection and quantification of intracranial hemorrhage, CINA-LVO for large vessel occlusion detection, and CINA-ASPECTS for automated ASPECTS scoring to support ischemic stroke assessment. All three tools run automatically on incoming scans and flag critical findings for radiologist review.
Yes. All three tools integrate via standard DICOM and run automatically on qualifying scans, with no manual trigger and no change to your existing workflow.
The radiologist, always. CINA flags and prioritizes suspected cases so they reach the right reader faster. Every case is still reviewed, interpreted and confirmed by a radiologist.
Each tool can be deployed independently. Running all three lets Avicenna.AI cover the full stroke pathway automatically, from hemorrhage detection to Large Vessel Occlusion Assessment.